MEGA-SQ: A method using the squeal function to find the optimal superposition of several quasi-flexible molecules

Medicinal Chemistry Research

Volumn 9, Issue 7-8, 1999, Pages 513-534

  Miller, Michael D ^a,b   Fluder, Eugene M ^a   Castonguay, Laurie A ^a   Culberson, J Chris ^a   Mosley, Ralph T ^a   Prendergast, Kris ^a   Kearsley, Simon K ^a   Sheridan, Robert P ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; 2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; ANGIOTENSIN RECEPTOR ANTAGONIST; CGP 47889; L 161664; L 741344; N ACETYLTRYPTOPHAN 3,5 BIS(TRIFLUOROMETHYL)BENZYL ESTER; NEUROKININ 1 RECEPTOR ANTAGONIST; SAREDUTANT; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; CONFORMATIONAL TRANSITION; DRUG DESIGN; DRUG STRUCTURE; MOLECULAR MODEL; PHARMACOPHORE;

EID: 0033390822     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. 1. Dammkoehler, R.A.; Karasek, S.F.; Shands, E.F.B.; Marshall, G.R. "Constrained search of conformational hyperspace." J. Comput.-Aided Molec. Design 1989, 3, 3-21.
2. 2. Sheridan, R.P.; Nilakantan, R.; Dixon, J.S.; Venkataraghavan, R. "The ensemble approach to distance geometry: application to the nicotinic pharmacophore." J. Med. Chem. 1986, 29, 899-906.
3. 3. Jain, A.N.; Diettrich, T.G.; Lathrop, R.H.; Chapman, D.; Critchlow, R.E.Jr.; Bauer, B.E.; Webster, T.A.; Lozano-Perez, T. "Compass: a shaped-based machine learning tool for drug design." J. Comput.-Aided Drug. Design 1994, 8, 635-652.
4. 4. Perkins, T.D.J; Dean, P.M. "An exploration of a novel strategy for superposing several flexible molecules." J. Comput.-Aided Drug. Design 1993, 7, 155-172.
5. 5. Martin, Y.C.; Bures, M.G.; Danaher, E.A.; DeLazzer, J.; Lico, I.; Pavlik, P.A. "A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists." J. Comput.-Aided Drug. Design 1993, 7, 83-102.
6. 6. Bures, M.G.; Danaher, E.; DeLazzer, J.; Martin, Y.C. "New molecular modeling tools using three-dimensional chemical substructures." J. Chem. Inf. Comput. Sci. 1994, 34, 218-223.
7. 7. Jones, G.; Willett, P.; Glen, R.C.; "A genetic algorithm for flexible molecular overlay and pharmacophore elucidation." J. Comput.-Aided Drug. Design 1995, 9, 532-549.
8. 8. Huang, P.; Kim, S.; Loew, G. "Development of a common 3-D pharmacophore for delta-opioid recognition form peptides and non-peptides using a novel computer program." J. Comput.-Aided Drug. Design 1997, 11, 21-28.
9. 9. Lemmen, C.; Lengauer, T.; Klebe, G. "FlexS: a method for fast flexible ligand superposition." J. Med. Chem. 1998, 41, 4502-4520.
10. 10. Hanschuh, S.; Wagener, M.; Gasteiger, J. "Superposition of three-dimensional chemical structures allowing for conformational flexibility by a hybrid method." J. Chem. Inf. Comput. Sci. 1998, 38, 220-232.
11. 11. Mestres, J.; Rohrer, D.C.; Maggiora, G.M. "A molecular-field-based-similarity study of non-nucleoside HIV-1 reverse transcriptase inhibitors." J. Comput.-Aided Molec. Design 1999, 13, 79-93.
12. 12. Sprague, P.W.; Hoffman, R. "Catalyst pharmacophore models and their utility as queries for searching 3D database." in Computer-Assisted Lead Finding and Optimization, Eds. van de Waterbeemd, H.; Testa, B.; Folkers. Wiley-VHC, New York, 1997 pp. 225-240.
13. 13. Martin, Y.C. "3D QSAR: current state, scope, and limitations." Perspectives in Drug Discovery and Design 1998, 12/13/14, 3-23.
14. 14. Norinder, U. "Recent progress in CoMFA methodology and related techniques." Perspectives in Drug Discovery and Design 1998, 12/13/14, 25-39.
15. 15. Willett, P. "A review of three-dimensional chemical retrieval systems." J. Chemometrics 1992, 6, 289-305.
16. 16. Manallack. D.T. "Getting that hit: 3D database searching in drug discovery." Drug Discovery Today, 1996, 1, 231-238.
17. 17. Paris, C.G. "Chemical structure handling by computer." Annual Review of Information Science and Technology 1997, 32, 270-337.
18. 18. Miller, M.D.; Sheridan, R.P.; Kearsley, S.K. "SQ - a program for rapidly producing pharmacophorically relevant molecular superpositions." J. Med. Chem. 1999, 42, 1505-1514.
19. 19. Kearsley, S.K.; Underwood, D.J.; Sheridan, R.P.; Miller, M.D. "Flexibases: a way to enhance the use of molecular docking methods." J. Comp.-Aided Molec. Design 1994, 8, 565-582.
20. 20. Gasteiger, J.; Rudolph, C.; Sadowski, J. "Automatic Generation of 3D-atomic coordinates for organic molecules." Tetrahedron Comp. Method. 1990, 3, 537-547.
21. 21. Feuston, B.; Miller, M.D.; Culberson, J.C.; Nachbar, R.N.; Kearsley, S.K. "Comparison of knowledge-based and distance geometry approach: generation of molecular conformations." (manuscript in preparation).
22. 22. Wexler, R.R.; Greenlee, W.J.; Irvin, J.D.; Goldberg, M.R.; Prendergast, K.; Smith, R.D.; Timmermans, P.B.M.W.M. "Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy." J. Med. Chem. 1996, 39, 625-656.
23. 23. Smith, R.D.; Chiu, A.T.; Wong, P.C.; Herblin, W.F.; Timmermans, P.B.M.W.M. "Pharmacology of nonpeptide angiotensin II receptor antagonists." Annu. Rev. Pharmacol. Toxicol. 1992, 32, 135-165.
24. 24. Prendergast, K.; Adams, K.; Greenlee, W.J.; Nachbar, R.B.; Patchett, A. A.; Underwood, D.J. "Derivation of a 3D pharmacophore model for the angiotensin-II site one receptor." J. Comp.-Aided Molec. Design 1994, 8, 491-512.
25. 25. Belvisi, L; Bravi, G; Scolastico, C.; Vulpetti, A.; Salimbeni, A.; Todeschini, R. "A 3D QSAR approach to the search for geometrical similarity in a series of angiotensin II receptor antagonists." J. Comput.-Aided Molec. Design 1994, 8, 211-220.
26. 26. de Laszlo, S.E.; Glinka, T.W.; Greenlee, W.J.; Ball, R.; Nachbar, R.B.; Prendergast, K. "The design, binding affinity prediction and synthesis of macrocyclic angiotensin II AT1 and AT2 receptor antagonists." Bioorg. & Med. Chem. Lett. 1996, 8, 923-928.
27. 27. McLean, S. "Nonpeptide antagonists of the NK1 tachykinin receptor." Medicinal Research Reviews 1996, 16, 297-317.
28. 28. Watling, K.J. "Nonpeptide antagonists herald new era in tachykinin research." TIPS 1992, 13, 266-269.
29. 29. Desai, M.C.; Vincent, L.A.; Rizzi, J.P. "Importance of parallel vectors and hydrophobic collapse of the aligned aromatic rings: discovery of a potent substance P antagonists." J. Med. Chem. 1994, 37, 4263-4266.
30. 30. Swain, C.J.; Fong, T.M.; Haworth, K.; Owen, S.N.; Seward, E.M.; Strader, C.D. "Quinuclidine-based NK1 antagonists, the role of benzhydryl." Bioorg. & Med. Chem. Lett. 1995, 12, 1261-1264.
31. 31. Takeuchi, Y.; Shands, E.F.B.; Beusen, D.D.; Marshall, G.R. "Derivation of a three-dimensional pharmacophore model of substance P angtagonists bound to the neurokinin-1 receptor." J. Med. Chem. 1998, 41, 3609-3623.
32. 32. MACCS Drug Data Report Licensed by Molecular Design Ltd., San Leandro, CA.